By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

uniQure 

Meibergdreef 61

  Amsterdam  1105 BA  Netherlands
Phone: 31-20-566-7394 Fax: 31-20-566-9272


SEARCH JOBS


Industry
Pharmaceutical






Company News
uniQure (QURE) Announces Conference Call And Webcast To Discuss Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial 1/7/2016 8:45:22 AM
uniQure (QURE) Announces Preliminary Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial 1/7/2016 8:42:02 AM
uniQure (QURE) Appoints Dan Soland As CEO 12/18/2015 8:35:06 AM
uniQure (QURE) Added To NASDAQ Biotechnology Index 12/14/2015 7:47:44 AM
uniQure (QURE) Announces Financial Results For Third Quarter 2015 And Provides Update On Product Pipeline And Company Developments 11/30/2015 12:10:04 PM
uniQure (QURE) Announces Financial Results For Third Quarter 2015 And Provides Update On Product Pipeline And Company Developments 11/30/2015 8:32:13 AM
uniQure (QURE) Announces Conference Call And Webcast To Discuss Third Quarter Financial Results And Corporate Update 11/23/2015 8:09:51 AM
uniQure (QURE) To Present At The Jefferies and Co. 2015 Global Healthcare Conference - London 11/12/2015 7:55:40 AM
uniQure (QURE) To Host Investor Day In New York City On October 15, 2015 10/7/2015 11:29:40 AM
Positive Topline Results Announced From Phase I/II Trial In Sanfilippo B Syndrome Patients Using uniQure (QURE)'s Novel AAV5-Based Gene Therapy 9/21/2015 8:45:05 AM
123456
//-->